Quantitative Systematic Strategies’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Quantitative Systematic Strategies’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-14,539	Closed	-$369K	–	770
2020 Q2	$369K	Buy	14,539 +216	+2%	+$4.65K	0.07%	375
2020 Q1	$263K	Sell	14,323 -4,756	-25%	-$92.4K	0.22%	169
2019 Q4	$420K	Buy	19,079 +7,095	+59%	+$143K	0.06%	372
2019 Q3	$172K	Buy	+11,984	New	+$171K	0.04%	419
2019 Q1	–	Sell	-30,828	Closed	-$330K	–	724
2018 Q4	$330K	Buy	30,828 +18,555	+151%	+$244K	0.07%	377
2018 Q3	$187K	Buy	12,273 +1,002	+9%	+$14.6K	0.04%	536
2018 Q2	$138K	Sell	11,271 -523	-4%	-$6.57K	0.03%	583
2018 Q1	$113K	Buy	+11,794	New	+$127K	0.02%	595

Other funds holding DRNA

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Quantitative Systematic Strategies's DRNA Position: Q3 2020 in Review

Quantitative Systematic Strategies sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q3 2020, closing a stake of 14,539 shares — an estimated $369K sold.

Quantitative Systematic Strategies first reported a position in DRNA in Q1 2018 and held it in 8 quarters. The position peaked at $420K in Q4 2019. 172 funds tracked by Wall St. Rank hold DRNA as of Q3 2020.

Quantitative Systematic Strategies reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Quantitative Systematic Strategies sold 14,539 Dicerna Pharmaceuticals, Inc. shares in Q3 2020, an estimated $369K.
Quantitative Systematic Strategies first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2018 and held it in 8 quarters.
Quantitative Systematic Strategies's Dicerna Pharmaceuticals, Inc. position peaked at $420K in Q4 2019.
172 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q3 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2020, filed 9 Nov 2020.